Tadalafil for early urinary symptoms after prostate surgery
Treatments studied
Part of Kidney & urinary, Mental health clinical trials.
This trial studies whether daily tadalafil (5 mg) can improve early urinary trouble and erection function after endoscopic prostate tissue removal. It may help men whose urinary symptoms continued even after prior medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 40 or older
- You had endoscopic prostate tissue removal and now have bothersome urinary symptoms
- Your urinary symptom score is high (IPSS over 15) and your comfort/bother score is at least 3
- Your urine flow is low (Qmax under 15 mL/second)
- You must be sexually active and not currently using erection medicines like PDE5 inhibitors
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking tadalafil (at 2.5 mg or 5 mg) along with tamsulosin is better for treating urinary symptoms caused by an enlarged prostate than taking tamsulosin alone. It aims to find the best dose combination to improve your quality of life.
This study tests whether taking tadalafil daily, either alone or with a second treatment, works better for men with erectile dysfunction who have not responded to on-demand pills. It aims to help men who have not had success with current treatments.
This study tests whether two compounds—L-citrulline (a natural amino acid) and tadalafil (a common erectile dysfunction medication)—work well together for men with mild to moderate erectile problems. The goal is to see if this combination safely improves sexual function.
This Phase 2 study tests how safe and effective a topical medicine (BZ371A) is for men after prostate surgery, with the goal of improving sexual recovery and monitoring side effects. You may be able to join if you meet specific timing, health, and medication criteria after radical prostatectomy.
This trial tests a new drug, DTT106, for men who have both erectile dysfunction and an enlarged prostate (BPH). It is for men already taking dutasteride and tamsulosin and aims to see if the new treatment improves erections better.
This study tests whether low-intensity shock wave therapy can help improve erectile function after robotic prostatectomy for low-risk prostate cancer. It is for men who already had fairly good erections before surgery and want to see if this non-invasive treatment can help their recovery.
Hear when a new Erectile Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.